117 related articles for article (PubMed ID: 20574135)
1. Coadministration of carvedilol attenuates nitrate tolerance by preventing cytochrome p450 depletion.
Nakahira A; Minamiyama Y; Takemura S; Hirai H; Sasaki Y; Okada S; Funae Y; Suehiro S
Circ J; 2010 Aug; 74(8):1711-7. PubMed ID: 20574135
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
[TBL] [Abstract][Full Text] [Related]
3. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
[TBL] [Abstract][Full Text] [Related]
4. Evidences for prevention of nitroglycerin tolerance by carvedilol.
El-Demerdash E
Pharmacol Res; 2006 Apr; 53(4):380-5. PubMed ID: 16503407
[TBL] [Abstract][Full Text] [Related]
5. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T
Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of carvedilol on nitrate tolerance--a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1201-6. PubMed ID: 9809926
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.
Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
J Am Coll Cardiol; 1998 Nov; 32(5):1194-200. PubMed ID: 9809925
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to nitrates with enhanced radical formation suppressed by carvedilol.
Fink B; Schwemmer M; Fink N; Bassenge E
J Cardiovasc Pharmacol; 1999 Dec; 34(6):800-5. PubMed ID: 10598122
[TBL] [Abstract][Full Text] [Related]
9. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate.
McVeigh GE; Hamilton P; Wilson M; Hanratty CG; Leahey WJ; Devine AB; Morgan DG; Dixon LJ; McGrath LT
Circulation; 2002 Jul; 106(2):208-13. PubMed ID: 12105160
[TBL] [Abstract][Full Text] [Related]
10. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance.
Hink U; Oelze M; Kolb P; Bachschmid M; Zou MH; Daiber A; Mollnau H; August M; Baldus S; Tsilimingas N; Walter U; Ullrich V; Münzel T
J Am Coll Cardiol; 2003 Nov; 42(10):1826-34. PubMed ID: 14642695
[TBL] [Abstract][Full Text] [Related]
11. Continuous administration of organic nitrate decreases hepatic cytochrome P450.
Minamiyama Y; Takemura S; Yamasaki K; Hai S; Hirohashi K; Funae Y; Okada S
J Pharmacol Exp Ther; 2004 Feb; 308(2):729-35. PubMed ID: 14593088
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Münzel T; Li H; Mollnau H; Hink U; Matheis E; Hartmann M; Oelze M; Skatchkov M; Warnholtz A; Duncker L; Meinertz T; Förstermann U
Circ Res; 2000 Jan; 86(1):E7-E12. PubMed ID: 10625313
[TBL] [Abstract][Full Text] [Related]
13. No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Takaoka A; Nakae I; Takahashi M; Matsumoto T; Liu Q; Mitsunami K; Kinoshita M
J Cardiovasc Pharmacol; 1998 Feb; 31(2):231-9. PubMed ID: 9475264
[TBL] [Abstract][Full Text] [Related]
14. Continuous treatment with organic nitrate affects hepatic cytochrome P450.
Minamiyama Y; Takemura S; Yamasaki K; Hai S; Hirohashi K; Okada S
Redox Rep; 2004; 9(6):360-4. PubMed ID: 15720833
[TBL] [Abstract][Full Text] [Related]
15. Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries.
Dou D; Zheng X; Qin X; Qi H; Liu L; Raj JU; Gao Y
Br J Pharmacol; 2008 Feb; 153(3):497-507. PubMed ID: 18037907
[TBL] [Abstract][Full Text] [Related]
16. Prazosin potentiates the acute hypotensive effects of nitroglycerin but does not attenuate nitrate tolerance in normal conscious rats.
Wang EQ; Fung HL
J Cardiovasc Pharmacol; 2004 Mar; 43(3):341-6. PubMed ID: 15076216
[TBL] [Abstract][Full Text] [Related]
17. Escape from tolerance of organic nitrate by induction of cytochrome P450.
Minamiyama Y; Imaoka S; Takemura S; Okada S; Inoue M; Funae Y
Free Radic Biol Med; 2001 Dec; 31(11):1498-508. PubMed ID: 11728822
[TBL] [Abstract][Full Text] [Related]
18. Increased nitric oxide concentrations in posterior hypothalamus and central sympathetic function on nitrate tolerance following subcutaneous nitroglycerin.
Ma SX; Ignarro LJ; Byrns R; Li XY
Nitric Oxide; 1999; 3(2):153-61. PubMed ID: 10369185
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: effects of dose and dosing protocol.
Wang EQ; Balthasar JP; Fung HL
Pharm Res; 2004 Jan; 21(1):114-20. PubMed ID: 14984265
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
